One of the key mediators of cardiovascular risk in obesity is the development of hypertension. Obesity is the principal modifiable risk factor for hypertension, and one of the major contributors to its very high prevalence. Nonetheless, the mechanisms underlying the dysregulation of blood pressure in obesity are incompletely understood. An impaired ability to handle a salt load, or salt-sensitivity, is regarded as an important mechanism for obesity-related hypertension. Salt-sensitivity is determined by the balance of salt-retaining and salt-excreting systems. One of the best-studied salt-retaining systems is the renin-angiotensin-aldosterone system (RAAS). Excess RAAS activation in obesity is well-established. The principal counter-regulatory system to the RAAS is the natriuretic peptide (NP) system. The NPs are natriuretic and vasodilatory molecules produced by the heart in response to increased chamber stress. However, little is known regarding changes in the NP axis in obesity. In preliminary work, we have shown that obese individuals have decreased circulating NP concentrations, which reverse with weight loss. However, resting NP levels may not adequately reflect the ability of the NP axis to respond to stimuli, emphasizing the need for more detailed physiologic studies, under controlled salt conditions and with standardized assessment of the NP and RAAS axes, and related target organs (kidney, heart, and vasculature). We postulate that obesity promotes a state of relative """"""""NP deficiency,"""""""" which leads to impaired NP responses to salt loading, increased salt-sensitivity and elevated blood pressure.
In Specific Aim 1, we will assess the NP and target organ responses to acute and chronic salt loading, in lean versus obese individuals.
In Aim 2, we will examine the effect of weight loss on the NP and target organ responses to acute and chronic salt loading. The proposed research represents a systematic effort to build upon the investigators'prior clinical investigations into the novel interactions between the NP axis, obesity, and cardiometabolic risk. These studies have the potential to provide important insight into the causes of hypertension in obesity. Furthermore, because the NP system is easily accessible to pharmacologic manipulation, establishing that """"""""NP deficiency"""""""" exists and defining its physiologic consequences could suggest novel approaches to the treatment and prevention of obesity-related cardiovascular disease.

Public Health Relevance

The development of high blood pressure in obese individuals leads to substantial morbidity and mortality, but how obesity promotes high blood pressure is not well understood. The proposed research investigates the role of hormones produced by the heart in the regulation of blood pressure and responses to dietary salt, which could have important implications for behavioral and pharmacologic treatments to lower cardiovascular risk in obesity.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Clinical and Integrative Diabetes and Obesity Study Section (CIDO)
Program Officer
Boyington, Josephine
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Massachusetts General Hospital
United States
Zip Code
Wasserman, David H; Wang, Thomas J; Brown, Nancy J (2018) The Vasculature in Prediabetes. Circ Res 122:1135-1150
Patel, Vivek G; Gupta, Deepak K; Terry, James G et al. (2017) Left Ventricular Function Across the Spectrum of Body Mass Index in African Americans: The Jackson Heart Study. JACC Heart Fail 5:182-190
Gupta, Deepak K; Daniels, Lori B; Cheng, Susan et al. (2017) Differences in Natriuretic Peptide Levels by Race/Ethnicity (From the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol 120:1008-1015
Arora, Pankaj; Wu, Connie; Hamid, Tariq et al. (2016) Acute Metabolic Influences on the Natriuretic Peptide System in Humans. J Am Coll Cardiol 67:804-812
Zhang, Haihua; Thoonen, Robrecht; Yao, Vincent et al. (2016) Regulation of B-type natriuretic peptide synthesis by insulin in obesity in male mice. Exp Physiol 101:113-23
Gupta, Deepak K; de Lemos, James A; Ayers, Colby R et al. (2015) Racial Differences in Natriuretic Peptide Levels: The Dallas Heart Study. JACC Heart Fail 3:513-519
Gupta, Deepak K; Wang, Thomas J (2015) Natriuretic Peptides and Cardiometabolic Health. Circ J 79:1647-55
Arora, Pankaj; Reingold, Jason; Baggish, Aaron et al. (2015) Weight loss, saline loading, and the natriuretic peptide system. J Am Heart Assoc 4:e001265
Mahmood, Syed S; Wang, Thomas J (2013) The epidemiology of congestive heart failure: the Framingham Heart Study perspective. Glob Heart 8:77-82
Ho, Jennifer E; Wang, Thomas J (2012) Growth differentiation factor 15: a canary in a coal mine? Clin Chem 58:3-5

Showing the most recent 10 out of 11 publications